The Europe Digital Therapeutics Market would witness market growth of 21.3% CAGR during the forecast period (2021-2027). Digital therapeutics is a term that refers to a section of digital health, which is a software driven evidence-based intervention.
There is a lot of potential in digital therapeutics to fulfil the unfulfilled requirements of patients, which traditional treatments & therapies could not fulfil. Thus, organizations that are using life science technologies to fill the gap between demand & supply of healthcare solutions along with faster product development would get more advantages than traditional life sciences enterprises.
Several companies across the industries are getting inspired and keen to explore the potential of the digital therapeutics market. Some technology giants are also planning to enter and transform the healthcare sector. Players are keen to know how digital therapeutics affect reimbursement policies and simultaneously exploring the way patient data collected via these products can be utilized to inform coverage. A few of the start-ups are also launching unique concepts to attract more investors.
Healthcare facilities across the world have a huge cost involved; many people could not afford a basic healthcare facility, which created the need for the solutions which can reduce healthcare costs. Digital therapeutics assist in decreasing the costs incurred in chronic diseases, by assisting patients or an insurance provider to monitor a person’s health status and also track it with the help of digital solutions. The cost of treatment of chronic diseases like diabetes has increased over the years. This increasing cost would be managed well by using digital therapeutics that is available by the providers to assist in managing diabetes. Digital therapeutics can help people in getting assistance for disease management and face the logistical challenges unwrapped by the doctors.
The Germany market dominated the Europe Respiratory Diseases Applications Market by Country 2020, thereby, achieving a market value of $109.9 million by 2027. The UK market is exhibiting a CAGR of 22.8% during (2021 - 2027). Additionally, The France market is poised to grow at a CAGR of 24.5% during (2021 - 2027).
Based on End Use, the market is segmented into Patients, Providers, Payers, Employers and Others. Based on Applications, the market is segmented into Diabetes, CNS Disease, Respiratory Diseases, Smoking Cessation, Obesity, CVD and others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Digital Therapeutics Market Size will Hit $14.5 Billion by 2027, at a CAGR of 21.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ResMed, Inc. (Propeller Health), Teladoc Health, Inc. (Livongo Health), Noom, Inc., Omada Health, Inc., Welldoc, Inc., Canary Health, Mango Health, Inc. (TrialCard, Incorporated), 2Morrow, Inc., Pear Therapeutics, Inc., and Mindstrong, Inc.
By End Use
By Application
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
